- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06400836
Nutrient Timing in Connection to Evening Exercise
Impact of Carbohydrate Timing on Glucose Metabolism and Substrate Oxidation Following High-Intensity Evening Aerobic Exercise in Athletes: A Randomized Controlled Study
Physical exercise (PE) significantly influences insulin sensitivity (IS), glucose control and overall metabolic health. While PE effectively enhances IS and glucose regulation, the timing of nutrient intake, before and after exercise, plays a crucial role in modulating its effects.
The aim of this study is to evaluate how pre- or post-evening exercise carbohydrate (CHO) ingestion influences glucose metabolism and substrate oxidation (fat/CHO) during exercise and after exercise in athletes during the nocturnal period and the morning after during an oral glucose tolerance test (OGTT).
Study Overview
Status
Intervention / Treatment
Detailed Description
The aim of this study is to evaluate how pre- or post-evening exercise carbohydrate (CHO) ingestion influences glucose metabolism and substrate oxidation (fat/CHO) during exercise and after exercise in athletes during the nocturnal period and the morning after during an oral glucose tolerance test (OGTT).
The primary objective is to assess glucose regulation during a 120-minute OGTT the following day.
The secondary objective is to investigate substrate metabolism (CHO and fat oxidation) during a 120-minute OGTT the following day.
Ten healthy, well-trained male endurance cyclists/triathletes, aged 19-45 years, are recruited via local contacts from the Gothenburg region, Sweden. The study is performed in accordance with the Declaration of Helsinki 2008 and is approved by the Swedish Ethical Review Authority (Dnr: 2022-03056-01). All participants gave their written informed consent before inclusion.
The study has a double-blind, randomized, placebo-controlled, crossover design.
After baseline assessment and determination of maximal oxygen uptake (VO2 max), participants undergo a familiarization cycle exercise trial. This trial serves a dual purpose: first, to establish the appropriate amount of CHO to be incorporated into the pre- or post-drink for subsequent cycle experimental trials, and second, to familiarize participants with the equipment and study protocol.
Three days prior to the cycle experimental trial, subcutaneous insertion of a glucose sensor for continuous glucose monitoring (CGM) takes place. Participants are randomly assigned to consume either a CHO drink or a placebo (PLA) drink (containing no energy) two hours prior to the cycle experimental trial that starts at 19:30. During the exercise trial, participants engage in submaximal cycling exercise at 70% of their maximal workload (Wmax), followed by a 25-minute time trial (TT). The total duration of the exercise session is approximately 90 minutes. Workload during the TT is individualized based on each participant's maximal work capacity (Wmax). During exercise, capillary glucose levels, heart rate, and rate of perceived exertion (RPE; Borg category scale 6-20) are measured. Additionally, respiratory gases are collected during 5-minute periods at every 15-minute interval to assess substrate utilization.
Immediately after completing the TT, participants switch to the opposite drink condition: those who initially received the CHO drink consume the PLA drink, and vice versa. The amount of CHO in the CHO drink consumed by each participant is precisely matched to the amount of CHO that the participant oxidizes during the exercise trial.
After the ingestion of the CHO- or placebo drink, participants fast overnight. CGM technology is used to measure interstitial glucose values during the night.
At 08:00, participants consume a 300mL solution containing 75g glucose for a 120-min OGTT. Capillary blood samples are collected at baseline and every 15 minutes during the OGTT. Respiratory gases are collected to measure substrate oxidation. The same protocol is reproduced the following week, with the reverse order of the test drink intake.
Three days preceding both control and experimental trials, participants are provided with a standardized diet consisting of pre-packaged meals that match their daily energy and macronutrient needs to prevent energy deficiency.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Bohuslän
-
Göteborg, Bohuslän, Sweden, 405 30
- Department of Food and Nutrition, and Sport Science, Centre for Health and Performance, University of Gothenburg, Gothenburg, Sweden
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Females and males
- 18-50 years
- Endurance fitness level of ≥40 mL O2/kg/min.
- Signed informed consent
Exclusion Criteria:
• Medical treatment and/or nutritional supplements that may affect glucose tolerance, substrate oxidation and performance capacity
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Carbohydrate drink
All study participants will receive the carbohydrate (CHO) drink and the placebo in a randomized, doubleblind crossover fashion.
The CHO drink and placebo products have similar appearance and taste.
|
The study aims to investigate how pre- or post evening exercise carbohydrate ingestion influences glucose metabolism and substrate oxidation (fat/CHO) during exercise and after exercise in athletes during the nocturnal period (21:00-06:00) and the morning after during an 120 minute oral glucose tolerance test (OGTT).
|
|
Placebo Comparator: Placebo
All study participants will receive the carbohydrate (CHO) drink and the placebo in a randomized, double-blind crossover fashion.
The CHO drink and placebo products have similar appearance and taste.
|
The study aims to investigate how pre- or post evening exercise carbohydrate ingestion influences glucose metabolism and substrate oxidation (fat/CHO) during exercise and after exercise in athletes during the nocturnal period (21:00-06:00) and the morning after during an 120 minute oral glucose tolerance test (OGTT).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To investigate change in glucose tolerance during a 75g glucose, 120 min oral glucose tolerance test (OGTT)
Time Frame: Comparing the change in glucose tolerance during the OGTT between baseline (no exercise) week 0, compared to interventions week 1 and week 2 involving previous evening exercise, with carbohydrates consumed either before or after exercise.
|
To quantify participants' glucose tolerance, the change in plasma glucose levels (mmol/L) will be measured over a 120-minute period following the ingestion of a standardized 75g glucose solution during an OGTT.
|
Comparing the change in glucose tolerance during the OGTT between baseline (no exercise) week 0, compared to interventions week 1 and week 2 involving previous evening exercise, with carbohydrates consumed either before or after exercise.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To investigate substrate oxidation during the oral glucose tolerance test (OGTT)
Time Frame: Comparing the change in substrate oxidation during the OGTT between baseline (no exercise) week 0, compared to interventions week 1 and week 2 involving previous evening exercise with carbohydrates being consumed either before or after exercise.
|
To quantify substrate oxidation rates (carbohydrate oxidation (g/minute) and fat oxidation (g/minute), the change in respiratory exchange ratios (RER) will be measured during the 120-minute OGTT period.
|
Comparing the change in substrate oxidation during the OGTT between baseline (no exercise) week 0, compared to interventions week 1 and week 2 involving previous evening exercise with carbohydrates being consumed either before or after exercise.
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To investigate performance capacity during a cycle ergometer time trial (TT).
Time Frame: Comparing the change in performance capacity between the interventions involving carbohydrates being consumed either before (week 1) or after the time trial (week 2). Note that respective arm will be randomized.
|
Performance capacity was assessed by measuring the time (seconds) required to complete a specific amount of work.
|
Comparing the change in performance capacity between the interventions involving carbohydrates being consumed either before (week 1) or after the time trial (week 2). Note that respective arm will be randomized.
|
|
To investigate substrate oxidation during 50 min submaximal evening exercise.
Time Frame: Comparing the change in substrate oxidation between the interventions involving previous evening exercise with carbohydrates being consumed either before (week 1) or after exercise (week 2). Note that respective arm will be randomized.
|
To quantify substrate oxidation rates (carbohydrate oxidation (g/minute) and fat oxidation (g/minute), the change in respiratory exchange ratios will be measured during the 50 min submaximal exercise.
|
Comparing the change in substrate oxidation between the interventions involving previous evening exercise with carbohydrates being consumed either before (week 1) or after exercise (week 2). Note that respective arm will be randomized.
|
|
To investigate nocturnal glucose regulation.
Time Frame: Comparing the change in glucose levels (mmol/L) during the period 21:00-06:00 between baseline (no exercise) week 0, compared to interventions week 1 and week 2 involving previous evening exercise, with CHO consumed either before or after exercise.
|
To quantify participants' nocturnal glucose regulation, the change in interstitial glucose levels (mmol/L) will be measured during the period 21:00-06:00 utilizing continuous glucose monitoring (CGM).
|
Comparing the change in glucose levels (mmol/L) during the period 21:00-06:00 between baseline (no exercise) week 0, compared to interventions week 1 and week 2 involving previous evening exercise, with CHO consumed either before or after exercise.
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Stefan Pettersson, Assoc. Prof., Department of Food and Nutrition, and Sport Science, University of Gothenburg, Sweden
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Dnr: 2022-03056-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Blood Glucose
-
Wageningen University and ResearchCompletedGlucose, Low Blood | Glucose, High BloodNetherlands
-
Inland Norway University of Applied SciencesUniversity of OsloCompletedBlood Glucose | Blood Glucose Related VariablesNorway
-
Ingredion IncorporatedKGK Science Inc.CompletedGlucose, Low Blood | Glucose, High Blood | Meals
-
Matthew GroutCompletedMood | Cognitive Performance | Glucose, Low Blood | Glucose, High BloodUnited Kingdom
-
Matthew GroutCompletedDiet Modification | Mood | Glucose, Low Blood | Glucose, High Blood
-
Weizmann Institute of ScienceCompletedGlucose Intolerance | Glucose, Low Blood | Glucose, High BloodIsrael
-
Ocean Spray Cranberries, Inc.Biofortis Innovation ServicesRecruiting
-
Ocean Spray Cranberries, Inc.CompletedBlood Glucose | Blood InsulinUnited States
-
University of ManitobaAgriculture and Agri-Food CanadaCompleted
-
University of CopenhagenDaniscoCompleted
Clinical Trials on Carbohydrate timing - carbohydrate intake before or after exercise
-
São Paulo State UniversityFederal University of Mato GrossoUnknown
-
Örebro University, SwedenCompletedDiabetes Mellitus, Type 1
-
Charite University, Berlin, GermanyCompletedObesity | Type 2 Diabetes MellitusGermany
-
University of CopenhagenDepartment of Biomedical Sciences; XLab, Center of Healthy AgingCompletedType 2 Diabetes and ExerciseDenmark
-
University of Castilla-La ManchaMinisterio de Economía y Competitividad, Spain; Servicio de Salud de Castilla-La...RecruitingExercise Training | Fasting, Intermittent | Metabolic Syndrome, Protection Against | Metformin | Angiotensin Hypertension | Statins | Angiotensin-Converting-Enzyme InhibitorSpain
-
Institut de Recherches Cliniques de MontrealCompleted
-
Centre Hospitalier Metropole SavoieCompletedDiet Habit | Type I Diabetes | Activity, Motor | ControlFrance
-
Julio RamirezUniversity of LouisvilleTerminatedOsteomyelitisUnited States